First Report of Hepatitis C Virus Genotype 6 Infection in India

Researchers in India have identified, for the first time, two patients with chronic liver disease - a 46-year-old man and a 52-year-old woman, both from eastern India - who were found to be infected with hepatitis C virus genotype 6 strains. These strains have been previously reported only from Hong Kong and Southeast Asia.

Determining the identity of the infecting hepatitis C virus (HCV) genotype has important implications for deciding the duration of antiviral therapy and ascertaining prognosis for the patient.

Of the six HCV genotypes, genotype 6 was thought to be restricted to countries of Southeast Asia, previously having been reported from Hong Kong and Thailand.

Case Reports

Patient 1 was a 46-year-old man from eastern India who presented for evaluation after a positive HCV antibody test. He provided a history of four episodes of jaundice, in 1981, 1982, 1992 and 2000, the first episode occurring after having received blood transfusion. He had received injections in vaccination camps conducted in his state.

His ALT level at presentation was 39 U/L (64 U/L is the upper limit of normal as estimated in healthy, volunteer blood donors at our hospital3). Liver biopsy showed mild chronic hepatitis with mild periportal fibrosis (modified HAI score 6/18, fibrosis score 2/6). The viral load (Amplicor HCV Monitor , version 2.0, Roche Diagnostics, USA) was 2.4 x 105 IU per mL of plasma. The patient was subsequently lost to follow-up.

Patient 2 was a 52-year-old woman with chronic renal failure from eastern India who had been receiving thrice-weekly hemodialysis sessions for 5 months prior to presentation at our center. On routine testing she was found to be HCV antibody positive. HCV viral load was 9 x 105 IU per mL of plasma.

ALT level was 35 U/L. The patient was followed up for three years and ALT enzyme estimations performed eight times showed stable levels (mean 44.5 U/L, range 30 to 54). This patient continues to exhibit low reactivity to HCV antibody.

Both patients were negative for hepatitis B surface antigen and antibody to HIV-1 and HIV-2.

There was no recorded history of travel outside India in the hospital charts of both patients. The second patient had undergone her hemodialysis sessions only in India.

Discussion

Prior identification of the infecting genotype will help in planning the optimal duration of treatment for patients in a cost-effective manner. Hui et. al. showed that HCV genotype 6 strains exhibit greater sustained virological response (SVR) as compared to genotype 1 when treated with interferon.

Additionally, this study showed that a longer course of interferon did not increase the SVR in patients with HCV genotype 6 infection.

With increasing globalization, the geographical isolation of certain HCV genotypes may become obsolete. Indian laboratories and physicians must take into consideration the possibility of encountering HCV genotype 6 strains among their patients. Their immune response, long-term prognosis, and response to interferon remain to be seen.

 Departments of Clinical Virology and Gastrointestinal Sciences, Christian Medical College, Vellore, India.

Reference

S Raghuraman, P Abraham, G Sridharan, and B S Ramakrishna. Hepatitis C virus genotype 6 infection in India. Indian Journal of Gastroenterology 24:72-73. 2005.

Additional Reading

Doi H, Apichartpiyakul C, Ohba KI, Mizokami M, Hotta H. Hepatitis C virus (HCV) subtype prevalence in Chiang Mai, Thailand, and identification of novel subtypes of HCV major type 6. J Clin Microbiol 1996;34:569-574. 

Hui CK, Yuen MF, Sablon E, On On Chan A, Chun Yu Wong B, Lai CL. Interferon and ribavarin therapy for chronic hepatitis C virus genotype 6: a comparison with genotype 1. J Infect Dis 2003;187:1071-1074.

McOmish F, Yap PL, Dow BC, Follett EA, Seed C, Keller AJ, et al . Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. J Clin Microbiol 1994;32:884-892.  

Ohno T, Mizokami M, Wu RR, Saleh MG, Ohba KI, Orito E, et al . New hepatitis C virus genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a and 6a. J Clin Microbiol 1997;35:201-207.

06/22/05


FDA-approved
HCV Treatments


——

Experimental
HCV Treatments


——

Index of All
Hepatitis C
Articles by Topic

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


HIV AND AIDS
| HEPATITIS B | HEPATITIS C | HIV / HBV CO-INFECTION | HIV / HCV CO-INFECTION | HEALTH
|
TESTS | INTERNET CONFERENCE REPORTS | LINKS | ABOUT US | CONTACT US